Illustrative image – not actual.Aurobindo Pharma has plans to raise Rs.125 crore via private placement, to fund its on-going restructuring programme.
The company’s board would be meeting on 13 December
2001 to consider this proposal. If cleared, an extraordinary meeting of
shareholders would be held a month later, to obtain their consent. Once
approved by the shareholders, the company would have to raise the necessary
funds within three months.
Aurobindo Pharma’s on-going restructuring programme envisages upgrading its facilities and attaining US FDA approvals, mainly to tap regulated markets.
